These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. Swanson LW; Hartman BK J Comp Neurol; 1975 Oct; 163(4):467-505. PubMed ID: 1100685 [TBL] [Abstract][Full Text] [Related]
12. Toxicologic Pathology Forum Opinion: Rational Approaches to Expanded Neurohistopathology Evaluation for Nonclinical General Toxicity Studies and Juvenile Animal Studies. Bolon B Toxicol Pathol; 2023 Aug; 51(6):363-374. PubMed ID: 38288942 [TBL] [Abstract][Full Text] [Related]
13. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today. Bolon B; Garman R; Jensen K; Krinke G; Stuart B; Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729 [TBL] [Abstract][Full Text] [Related]
14. Neuropathology standards: what constitutes an optimal histomorphologic evaluation of the nervous system in general toxicity studies. Houle CD Toxicol Pathol; 2011 Oct; 39(6):1010-2. PubMed ID: 21859885 [TBL] [Abstract][Full Text] [Related]
15. Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies. Sellers RS; Morton D; Michael B; Roome N; Johnson JK; Yano BL; Perry R; Schafer K Toxicol Pathol; 2007 Aug; 35(5):751-5. PubMed ID: 17849358 [TBL] [Abstract][Full Text] [Related]
16. Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies. Keirstead ND; Janovitz EB; Meehan JT; LeRoy BE; Megill JR; Peterson RA; Masson RG; Marxfeld HA Toxicol Pathol; 2019 Jun; 47(4):461-468. PubMed ID: 31018785 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies. Burkhardt JE; Pandher K; Solter PF; Troth SP; Boyce RW; Zabka TS; Ennulat D Toxicol Pathol; 2011 Dec; 39(7):1129-37. PubMed ID: 22116771 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of various areas of the nervous system of hens to TOCP-induced delayed neuropathy. Classen W; Gretener P; Rauch M; Weber E; Krinke GJ Neurotoxicology; 1996; 17(3-4):597-604. PubMed ID: 9086480 [TBL] [Abstract][Full Text] [Related]
19. Compilation of international regulatory guidance documents for neuropathology assessment during nonclinical general toxicity and specialized neurotoxicity studies. Bolon B; Bradley A; Butt M; Jensen K; Krinke G; Mellon RD Toxicol Pathol; 2011 Jan; 39(1):92-6. PubMed ID: 21119055 [TBL] [Abstract][Full Text] [Related]
20. Neuropathology Evaluation in Juvenile Toxicity Studies in Rodents: Comparison of Developmental Neurotoxicity Studies for Chemicals With Juvenile Animal Studies for Pediatric Pharmaceuticals. Bolon B; Dostal LA; Garman RH Toxicol Pathol; 2021 Dec; 49(8):1405-1415. PubMed ID: 34620000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]